Alam MM. Prevalence of type 2 diabetes mellitus complications in human. 2021, Chattogram Veterinary & Animal| Sciences University.

(IDF), I.A.f.t.P.o.B.I.I.D.F. Diabetic retinopathy: a call for global action. 2020.

Teo ZL, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580–91.

Article  PubMed  Google Scholar 

Bourne R, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e130–43.

Article  Google Scholar 

Patel D, et al. Social determinants of health and impact on screening, prevalence, and management of diabetic retinopathy in adults: a narrative review. J Clin Med. 2022;11(23):7120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mudaliar S, Hupfeld C, Chao DL. SGLT2 inhibitor–induced low-grade ketonemia ameliorates retinal hypoxia in diabetic retinopathy—a novel hypothesis. J Clin Endocrinol Metab. 2021;106(5):1235–44.

Article  PubMed  Google Scholar 

Sivaprasad S, Sen S, Cunha-Vaz J. Perspectives of diabetic retinopathy—challenges and opportunities. Eye. 2023;37(11):2183–91.

Article  PubMed  Google Scholar 

Shukal DK, Malaviya PB, Sharma T. Role of the AMPK signalling pathway in the aetiopathogenesis of ocular diseases. Hum Exp Toxicol. 2022;41:09603271211063165.

Article  CAS  Google Scholar 

González P, et al. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11):9352.

Article  PubMed  PubMed Central  Google Scholar 

Wang Z, et al. Recent advances in the treatment and delivery system of diabetic retinopathy. Front Endocrinol. 2024;15:1347864.

Article  Google Scholar 

Wallsh JO, Gallemore RP. Anti-VEGF-resistant retinal diseases: a review of the latest treatment options. Cells. 2021;10(5):1049.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahr TA, Bakri SJ. Update on the management of diabetic retinopathy: anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy. Life. 2023;13(5):1098.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xia H-Q, et al. Molecules related to diabetic retinopathy in the vitreous and involved pathways. Int J Ophthalmol. 2022;15(7):1180.

Article  PubMed  PubMed Central  Google Scholar 

Chatziralli I, Loewenstein A. Intravitreal anti-vascular endothelial growth factor agents for the treatment of diabetic retinopathy: a review of the literature. Pharmaceutics. 2021;13(8):1137.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatti JS, et al. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives. Free Radic Biol Med. 2022;184:114–34.

Article  CAS  PubMed  Google Scholar 

Lin KY, et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322–5.

Article  PubMed  PubMed Central  Google Scholar 

Huang D, et al. Racial and socioeconomic differences correlate with healthcare disparities in patients with diabetic retinopathy. Int J Ophthalmol Visual Sci. 2024;12(2):30–9.

Article  Google Scholar 

Sanjiv N, et al. Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: a review. J Natl Med Assoc. 2022;114(2):123–40.

PubMed  Google Scholar 

Yu MG, et al. Protective factors and the pathogenesis of complications in diabetes. Endocr Rev. 2024;45(2):227–52.

Article  CAS  PubMed  Google Scholar 

Shah J, et al. Dietary intake and diabetic retinopathy: a systematic review of the literature. Nutrients. 2022;14(23):5021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

(NCHS) NCFHS. National health and nutrition examination survey 2018–2021. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), 2021.

van der Heijden AA, et al. Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia. 2020;63:1110–9.

Article  PubMed  PubMed Central  Google Scholar 

Ikram MA, et al. Objectives, design and main findings until 2020 from the Rotterdam study. Eur J Epidemiol. 2020;35:483–517.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen CTN, et al. Sociodemographic variables associated with risk for diabetic retinopathy. Clin Diabetes Endocrinol. 2022;8(1):7.

Article  PubMed  PubMed Central  Google Scholar 

Cai CX, et al. Social determinants of health impacting adherence to diabetic retinopathy examinations. BMJ Open Diabetes Research & Care. 2021;9(1):e002374.

Article  Google Scholar 

Achigbu EO, et al. Assessing the barriers and facilitators of access to diabetic retinopathy screening in sub-Saharan Africa: a literature review. Eye. 2024;38(11):2028–35.

Article  PubMed  Google Scholar 

Natarajan H, et al. Future risk of diabetes among Indians with metabolic and phenotypic obesity: results from the 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES–158). Acta Diabetol. 2021;58:1051–8.

Article  CAS  PubMed  Google Scholar 

Pieczynski J, Kuklo P, Grzybowski A. The role of telemedicine, in-home testing and artificial intelligence to alleviate an increasingly burdened healthcare system: diabetic retinopathy. Ophthalmol Ther. 2021;10(3):445–64.

Article  PubMed  PubMed Central  Google Scholar 

Singh LP, Devi TS. Potential combination drug therapy to prevent redox stress and mitophagy dysregulation in retinal müller cells under high glucose conditions: implications for diabetic retinopathy. Diseases. 2021;9(4):91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta S, Thool AR. A narrative review of retinopathy in diabetic patients. Cureus, 2024;16(1)

Burn H, et al. Eye care delivery models to improve access to eye care for Indigenous peoples in high-income countries: a scoping review. BMJ Glob Health. 2021;6(3):e004484.

Article  PubMed  PubMed Central  Google Scholar 

Cully M. Findings from DCCT—glycaemic control prevents diabetes complications. N Engl J Med. 1993;329:977–86.

Google Scholar 

Lundeen EA, et al. Prevalence of diabetic retinopathy in the US in 2021. JAMA Ophthalmol. 2023;141(8):747–54.

Article  PubMed  PubMed Central  Google Scholar 

Scanlon PH. The contribution of the English NHS diabetic eye screening programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. Acta Diabetol. 2021;58(4):521–30.

Article  PubMed  PubMed Central  Google Scholar 

Wang YX, et al. High myopia as risk factor for the 10-year incidence of open-angle glaucoma in the Beijing Eye Study. Br J Ophthalmol. 2023;107(7):935–40.

Article  PubMed  Google Scholar 

Oluleye T, et al. Macular diseases in Ibadan, Nigeria. Niger J Clin Pract. 2021;24(3):341–4.

Article  CAS  PubMed  Google Scholar 

Vivanco-Rojas O, et al. Risk factors for diabetic retinopathy in Latin America (Mexico) and the world: a systematic review and meta-analysis. J Clin Med. 2023;12(20):6583.

Article  CAS  PubMed  PubMed Central